A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
Year: 2008
Type: article
Study design: Clinical Trial
Source: European Journal Of Haematology
Institutions: Copenhagen University Hospital, Rigshospitalet, Herlev Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: belinostat, histone deacetylase inhibitors, hydroxamate, multiple myeloma, diffuse large cell lymphoma, chronic lymphocytic leukemia, dose-limiting toxicity, maximum tolerated dose, renal failure, tumor lysis syndrome, drug safety, stable disease, status epilepticus, lymphopenia, fatigue, nausea and vomiting
Open Access status: closed
OpenAlex ID: W1991376723
